Read + Share
Amedeo Smart
Independent Medical Education
Lu K, Woodward BD, Boys J, Onaitis M, et al. Brief Report: Evaluation of Molecular Profiling Strategies for Neoadjuvant Osimertinib in Stage IIIA EGFR-Mutant NSCLC. Clin Lung Cancer 2024;25:e58-e61.PMID: 37852849
Email
LinkedIn
Facebook
Twitter
Privacy Policy